Rentschler is growing continuously

August 7, 2017 Rentschler is growing continuously

Growth is driven by the international market

Rentschler has invested continuously in new plants in the recent years. Last year, the capacity was more than doubled. "The growth of Rentschler is increasingly driven by the international market," says Dr. Frank Mathias, CEO of Rentschler. "Quality Made in Germany is highly popular in this sector."

Furthermore, he stated in an interview with a regional newspaper: “We have invested around 50 million euros since 2012 and increased the total bioreactor volume to around 16,000 liters. This year, the focus is on efficiency, e.g. optimize the premises for the initial cultivation of cell cultures and purification of the biopharmaceutical active ingredients at the end of a manufacturing cycle."

The number of employees is increasing with plant growth. Currently Rentschler employs 771 people. Over the past 15 months, 210 new employees have been recruited. In the current fiscal year, more than 120 positions are to be occupied.

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication